Treatment of the postmenopausal woman : basic and clinical aspects /

Saved in:
Bibliographic Details
Edition:3rd ed.
Imprint:Burlington, MA : Academic Press, 2007.
Description:xiv, 894 p. : ill. (some col.) ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/6635826
Hidden Bibliographic Details
Other authors / contributors:Lobo, Rogerio A.
ISBN:9780123694430 (alk. paper)
0123694434 (alk. paper)
Notes:Includes bibliographical references and index.
committed to retain 20170930 20421213 HathiTrust
Table of Contents:
  • Contributors
  • Preface
  • 1. The Menopause: A Signal for the Future
  • Section I. Basics to Enhance Our Understanding
  • 2. Molecular Pharmacology of Estrogen and Progesterone Receptors
  • 3. Genetic Programming in Ovarian Development and Oogenesis
  • 4. Basic Biology: Ovarian Anatomy and Physiology
  • 5. Endocrine Changes During the Perimenopause
  • 6. Epidemiology of Menopause: Demographics, Environmental Influences, and Ethnic and International Differences in the Menopausal Experience
  • Section II. Ovarian Senescence and Options
  • 7. Premature Ovarian Failure
  • 8. Reproductive Options for Perimenopausal and Menopausal Women
  • Section III. The Perimenopause
  • 9. Neuroendocrine Regulation of the Perimenopause Transition
  • 10. Changes in the Menstrual Pattern During the Menopause Transition
  • 11. Decisions Regarding Treatment During the Menopause Transition
  • 12. Use of Contraceptives for Older Women
  • Section IV. Changes Occurring After Menopause
  • 13. Menopausal Hot Flashes
  • 14. Clinical Effects of Sex Steroids on the Brain
  • 15. Impact of the Changing Hormonal Milieu on Psychological Functioning
  • 16. Connective Tissue Changes in the Menopause and with Hormone Replacement Therapy
  • 17. Menopause and the Skin
  • 18. Urogenital Symptoms around the Menopause and Beyond
  • 19. Vulvovaginal Complaints
  • 20. Sexuality: Clinical Implications from Epidemiologic Studies
  • Section V. Brain Function
  • 21. Menopause and Cognition
  • 22. Cognitive Health in the Postmenopausal Woman
  • 23. The Role of Sex Steroids in Alzheimer's Disease: Prevention and Treatment
  • 24. Estrogens and Depression in Women
  • Section VI. Bone Changes
  • 25. Pathogenesis of Osteoporosis
  • 26. Assessment of Bone Density and Bone Strength
  • 27. Biochemical Markers of Bone Turnover
  • 28. Interventions for Osteoporosis
  • 29. Treatment of Osteoporosis
  • 30. Potentials of Estrogens in the Prevention of Osteoarthritis: What Do We Know and What Questions are Still Pending?
  • Section VII. Cardiovascular
  • 31. Epidemiology and Risk Factors of Cardiovascular Disease in Postmenopausal Women
  • 32. Mechanisms of Action of Estrogen on the Cardiovascular System
  • 33. Lipids and Lipoproteins and Effects of Hormone Therapy
  • 34. The Effects of Hormone Therapy on Inflammatory, Hemostatic, and Fibrinolytic Markers in Postmenopausal Women
  • 35. Hormone Therapy and Hemostasis
  • 36. Risk of Pulmonary Embolism/Venous Thrombosis
  • 37. Glucose Metabolism After Menopause
  • 38. Stage of Reproductive Life, Atherosclerosis Progression and Estrogen Effects on Coronary Artery Atherosclerosis
  • 39. Randomized Controlled Trials and the Effects of Postmenopausal Hormone Therapy on Cardiovascular Disease: Facts, Hypotheses, and Clinical Perspective
  • Section VIII. Neoplasia
  • 40. Body Weight, Menopausal Hormone Therapy, and Risk of Breast Cancer
  • 41. Postmenopausal Breast Surveillance
  • 42. Endometrial Cancer and Hormonal Replacement Therapy
  • 43. Ovarian Cancer and Its Detection
  • 44. Hormone Replacement Therapy in Menopause and Breast, Colorectal, and Lung Cancer: An Update
  • Section IX. Clinical Trials and Observational Data
  • 45. The Women's Health Initiative-Data and Discussion
  • 46. Postmenopausal Hormone Therapy in the 21st Century: Reconciling Findings from Observational Studies and Randomized Clinical Trials
  • 47. Morbidity and Mortality Changes with Hormone Therapy
  • Section X. Life Cycle and QOL
  • 48. Issues Relating to Quality of Life in Postmenopausal Women and Their Measurement
  • 49. Role of Exercise and Nutrition
  • 50. Herbs, Phytoestrogens, and Other CAM Therapies
  • Section XI. Urinary Symptoms and Pelvic Support
  • 51. Lower Urinary Tract Disorders in Postmenopausal Women
  • 52. Pelvic Organ Prolapse in Postmenopausal Women
  • Section XII. Hormonal Therapy
  • 53. Pharmacology of Estrogens
  • 54. Structure-Function Relationships, Pharmacokinetics, and Potency of Orally and Parenterally Administered Progestogens
  • 55. Intervention: Androgens
  • 56. Future Strategies in Climacteric Medicine
  • Section XIII. Some Alternative Medical Therapies
  • 57. Alternative Therapy: Dehydroepiandrosterone for Menopausal Hormone Replacement
  • 58. Melatonin
  • 59. Selective Estrogen Receptor Modulators
  • 60. Tibolone: Selective Tissue Estrogen Activity Regulator Utilization in Postmenopausal Women
  • Section XIV. Women's Centers, Information Needed for Clinical Trials, and the Future
  • 61. Integrated Adult Women's Medicine: A Model for Women's Health Care Centers
  • 62. Clinical Trials in Postmenopausal Hormone Therapy
  • 63. The Future of Therapy and the Role of Hormone Therapy
  • Subject Index